BioSpace News Archive

Biotech Bay

Kaiser Permanente Launches Social Health Network to Address Social Needs on a Broad Scale

Transformative social health network will help millions address social needs including food, housing and transportation.

May 6, 2019
·
4 min read
Biotech Beach

Progenity to Showcase New Data at Digestive Disease Week®

Progenity, Inc., a privately held biotechnology company developing precision medicine solutions across genomic/epigenomic, proteomic, and microbiomic diagnostic and therapeutic platforms, this week announced three upcoming poster presentations.

May 6, 2019
·
3 min read
Business

Ballad Health and Premier Inc. Partner on Enterprise-wide Performance Improvement Initiative

Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, has expanded its partnership with Ballad Health, an integrated health system that serves 29 counties across four Southeastern states

May 6, 2019
·
5 min read
Policy

BioTime Announces Issuance of U.S. Patent for Method of Reducing Cavitation in Patients with Acute Spinal Cord Injury

The issued patent would have a term that expires no earlier than 2036.

May 6, 2019
·
8 min read
Biotech Beach

ImpediMed Announces PREVENT Interim Results – “Practice-Changing”

ImpediMed Limited (ASX:IPD), a global provider of medical technology to non-invasively measure, monitor and manage tissue composition and fluid status using bioimpedance spectroscopy (BIS), today announces the publication of the peer-reviewed manuscript of the PREVENT interim analysis.

May 6, 2019
·
4 min read
Genetown

IMPACT Melanoma Gears Up for Busy Melanoma Awareness Month

National non-profit organization, IMPACT Melanoma, has a dizzying schedule as they rally the collective troops to put their already magnified awareness initiatives under the microscope and bolster outreach.

May 6, 2019
·
3 min read
Genetown

Instrumentation Laboratory Worldwide Sales Top $1 Billion In 2018

Instrumentation Laboratory (IL) today announced total worldwide sales in 2018 of $1,047 M (€887 M), with total growth of 6.2% over 2017, in local currencies.

May 6, 2019
·
5 min read
Pharm Country

SCYNEXIS Presents Data at ACOG 2019 Further Supporting a Future NDA Submission of Oral Ibrexafungerp for Vulvovaginal Candidiasis (VVC)

SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company delivering innovative therapies for difficult-to-treat and often life-threatening infections, today announced data demonstrating the potential of ibrexafungerp as an agent to address VVC.

May 6, 2019
·
5 min read
BioForest

Nass Valley Gateway Enters into Letter of Intent with CSB Supply BV to Supply CBD Products for Distribution under Nass Valley’s Brand

Nass Valley Gateway Ltd. (the “Company” or “Nass Valley”), trading on the Canadian Securities Exchange (“CSE”) under the trading Symbol “NVG” and on Deutsche Boerse Frankfurt under the trading Symbol 3NVN, is pleased to announce the signing of a letter of intent (“LOI”) with CSB Supply BV (“CSB”).

May 6, 2019
·
2 min read
Policy

Michigan Mesothelioma Victims Center Now Appeals to a Power Plant or Energy Worker in Michigan With Mesothelioma or Asbestos Exposure Lung Cancer to Call for Direct Access to Attorney Erik Karst for Better Compensation Claim Results

The Michigan Mesothelioma Victims Center is appealing to a power plant or energy worker in Michigan who has recently been diagnosed with mesothelioma or asbestos exposure lung cancer to call them anytime at 800-714-0303 for direct access to attorney Erik Karst of the law firm of Karst von Oiste.

May 6, 2019
·
3 min read